Dalton Greiner Hartman Maher & Co. Invests $227,000 in Aspen Aerogels Inc (NYSE:ASPN)

Dalton Greiner Hartman Maher & Co. bought a new position in shares of Aspen Aerogels Inc (NYSE:ASPN) during the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund bought 38,400 shares of the construction company’s stock, valued at approximately $227,000. Dalton Greiner Hartman Maher & Co. owned about 0.16% of Aspen Aerogels at the end of the most recent reporting period.

Several other institutional investors also recently modified their holdings of ASPN. Russell Investments Group Ltd. boosted its holdings in shares of Aspen Aerogels by 2,335.0% during the 2nd quarter. Russell Investments Group Ltd. now owns 48,699 shares of the construction company’s stock worth $347,000 after purchasing an additional 46,699 shares during the last quarter. Boston Partners acquired a new position in shares of Aspen Aerogels during the 2nd quarter worth approximately $440,000. Morgan Stanley lifted its holdings in Aspen Aerogels by 8.2% in the second quarter. Morgan Stanley now owns 83,203 shares of the construction company’s stock valued at $593,000 after acquiring an additional 6,288 shares during the last quarter. Wedge Capital Management L L P NC acquired a new position in Aspen Aerogels in the second quarter valued at approximately $735,000. Finally, Worth Venture Partners LLC acquired a new position in Aspen Aerogels in the second quarter valued at approximately $1,481,000. Institutional investors and hedge funds own 68.03% of the company’s stock.

A number of research analysts recently commented on the company. ValuEngine cut Aspen Aerogels from a “strong-buy” rating to a “buy” rating in a report on Wednesday, September 4th. Zacks Investment Research cut Aspen Aerogels from a “buy” rating to a “hold” rating in a report on Wednesday, October 2nd. Finally, HC Wainwright reiterated a “buy” rating and issued a $10.00 price objective on shares of Aspen Aerogels in a report on Friday, August 2nd.

ASPN opened at $6.02 on Friday. Aspen Aerogels Inc has a one year low of $1.60 and a one year high of $7.50. The business’s 50 day moving average price is $6.05 and its 200 day moving average price is $5.37. The company has a current ratio of 1.60, a quick ratio of 1.08 and a debt-to-equity ratio of 0.08.

Aspen Aerogels (NYSE:ASPN) last released its quarterly earnings data on Thursday, August 1st. The construction company reported ($0.22) EPS for the quarter, missing analysts’ consensus estimates of ($0.16) by ($0.06). Aspen Aerogels had a negative net margin of 27.30% and a negative return on equity of 37.52%. The business had revenue of $29.53 million during the quarter, compared to analyst estimates of $30.92 million. As a group, analysts predict that Aspen Aerogels Inc will post -0.54 earnings per share for the current year.

Aspen Aerogels Company Profile

Aspen Aerogels, Inc, an aerogel technology company, designs, develops, manufactures, and sells aerogel insulation products primarily for use in the energy infrastructure and building materials markets worldwide. The company provides Pyrogel XT-E that reduces the risk of corrosion under insulation in energy infrastructure operating systems; Pyrogel HPS for applications within the power generation market with operating temperatures greater than 400 C; Pyrogel XTF to provide strong protection against fire; Cryogel Z for sub-ambient and cryogenic applications in the energy infrastructure market; and Spaceloft Subsea for use in pipe-in-pipe applications in offshore oil production.

See Also: Trading signals using Bollinger bands

Want to see what other hedge funds are holding ASPN? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Aspen Aerogels Inc (NYSE:ASPN).

Institutional Ownership by Quarter for Aspen Aerogels (NYSE:ASPN)

Receive News & Ratings for Aspen Aerogels Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aspen Aerogels and related companies with MarketBeat.com's FREE daily email newsletter.